Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01118819 · ClinicalTrials.gov registry record · Phase 1
Safety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies
A Phase 1 study, sponsored by BioMed Valley Discoveries.
- Terminated
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT01118819: Clinical Trial Phase 1 study, sponsored by BioMed Valley Discoveries.
NCT01118819 is a Phase 1 study that was terminated before completion, run by BioMed Valley Discoveries. The registered enrollment target is 5 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01118819, a Phase 1 study, was terminated before completion, sponsored by BioMed Valley Discoveries.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
This protocol will examine the safety of intravenous administration of Clostridium novyi-NT spores in patients with treatment-refractory solid tumor malignancies. This investigational study will measure anti-tumor activity of C. novyi-NT administered intravenously in patients with treatment-refractory solid tumor malignancies.
Interventions
- BIOLOGICAL Clostridium novyi-NT spores
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2011-04 |
| Est. Completion | 2013-06 |
| Phase | Phase 1 |
Why NCT01118819 stopped before completion
NCT01118819 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Clostridium novyi-NT spores is the first listed.
NCT01118819 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01118819 about?
NCT01118819 is a clinical study titled "Safety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies". This protocol will examine the safety of intravenous administration of Clostridium novyi-NT spores in patients with treatment-refractory solid tumor malignancies. This investigational study will measure anti-tumor activity of C. novyi-NT administered intravenously in patients with treatment-refracto...
What is the current status of trial NCT01118819?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2011-04. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01118819?
The interventions under investigation include: Clostridium novyi-NT spores (BIOLOGICAL).
Who is sponsoring clinical trial NCT01118819?
This trial is sponsored by BioMed Valley Discoveries, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01118819's enrollment target sits among peer trials
5 1989th of 2000 higher than 6 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia